Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Zhengye Biotechnology Holding Limited

Zhengye Biotechnology Holding Limited (ZYBT) Stock Overview

Explore Zhengye Biotechnology Holding Limited’s financial performance, market position, analyst ratings, and future outlook.

ZYBT●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$1.63
$0.00(0.00%)
U.S. Market opens in 7h 18m

Zhengye Biotechnology Holding Limited (ZYBT)

Meyka AI Score

Z

Key Financials

Market Cap77.2M
P/E Ratio-7.43
EPS (TTM)$-0.22
ROE-0.27%
Fundamental Analysis

AI Price Forecasts

1 Month$-1.89
3 Months$0.00
1 Year Target$0.00

ZYBT Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Zhengye Biotechnology Holding Limited (NASDAQ: ZYBT) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Zhengye Biotechnology Holding Limited's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ZYBT on the NASDAQ shows an RSI of 48.30, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Zhengye Biotechnology Holding Limited's NASDAQ-traded stock include a P/E ratio of -7.43 and a market capitalization of 77.2M. Combined with our AI analysis, these give both institutional and retail investors a clear view of ZYBT on the NASDAQ.

Price Performance (NASDAQ: ZYBT)

1-Day Change
N/A
5-Day Change
-9.94%
1-Month Change
22.56%
3-Month Change
103.44%
6-Month Change
111.69%
Year-to-Date (YTD) Change
41.74%
1-Year Change
-83.28%
3-Year Change
-66.46%
5-Year Change
-66.46%
All-Time (Max) Change
-66.46%

Contact Information

https://www.jlzybio.com
86 432 6304 7008
No.1 Lianmeng Road, Jilin, JI, 132101

Company Facts

2,690 Employees
IPO DateJan 7, 2025
CountryCN
Actively Trading

Frequently Asked Questions